Study of Two Nasal Sedation medicines in Children Undergoing Dental treatment

Intranasal Sedation In Children : A Comparative Evaluation of Dexmedetomidine And Midazolam : A Clinical Study - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109651

Enrollment

Registered

2026-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Intranasal Dexmedetomidine: After confirming pre-procedural fasting status patient will be administered Dexmedetomidine intranasally equally in both nostrils according to the weight of

Eligibility

Inclusion criteria

Inclusion criteria: Children aged between 5-10 years with ASA score 1 requiring sedation for dental extractions and with failure of non-pharmacological behaviour management technique.

Exclusion criteria

Exclusion criteria: Patient deemed unfit by anaesthetist and allergic or hypersensitive to the drugs being used also children with systemic medical illness

Design outcomes

Primary

Measure	Time frame
Intranasal dexmedetomidine is anticipated to provide superior anxiolysis with better sedation quality and improved patient co-operation compared to midazolam .Timepoint: at base	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Shantanu R Choudhari

Government Dental College and Hospital Ahmedabad Gujarat India

shandent1@gmail.com07922682070

Outcome results